We are seeking an accomplished HEOR leader to define and drive global health economics and outcomes research strategies for a growing portfolio of marketed specialty medicines. In this senior leadership role, you will shape evidence-generation programmes that demonstrate the clinical, economic, and humanistic value of innovative therapies, supporting healthcare decision-making and patient access. You will focus initially on rheumatology while collaborating with global teams to prepare for future product launches and portfolio expansion. Working closely with Market Access, Medical Affairs, Real World Evidence, and Pipeline HEOR, you will ensure a seamless evidence strategy throughout the product lifecycle. You will also influence global pricing, reimbursement, and Health Technology Assessment (HTA) strategies through scientifically robust research and stakeholder engagement. This is an opportunity to combine scientific leadership, strategic influence, and team development while contributing to improved outcomes for patients living with severe autoimmune diseases.
Global HEOR Strategy: Own and lead the multi-year HEOR evidence-generation strategy for marketed products across relevant therapeutic areas, initially focusing on rheumatology. Ensure alignment with brand, medical, market access, and pricing strategies while demonstrating product value to payers, HTA organisations, healthcare providers, and patients worldwide.
Strategic Planning and Budget Management: Develop, justify, and manage the HEOR investment strategy and associated multi-million-dollar budgets. Prioritise research initiatives across indications, geographical markets, and methodologies while ensuring delivery within agreed budgets and timelines.
Executive and Governance Leadership: Represent Global HEOR in global brand, launch readiness, value assessment, and evidence governance forums. Provide strategic recommendations on value evidence, pricing-related research, reimbursement considerations, and HTA risk mitigation.
Scientific Team Leadership: Lead, mentor, and develop HEOR scientists and cross-functional contributors. Establish scientific quality standards, review research protocols and deliverables, and strengthen technical capabilities across the organisation.
Pipeline and Marketed Product Alignment: Collaborate with Pipeline HEOR teams to ensure smooth transitions of evidence responsibilities for indications progressing from Phase 3 development to commercial launch. Incorporate market-facing insights into development-stage evidence strategies.
Real World Evidence Collaboration: Partner with Real World Evidence teams to align registry studies, claims analyses, chart reviews, and prospective observational research with HEOR and HTA requirements, avoiding duplication and maximising the value of evidence-generation investments.
Economic and Outcomes Research: Direct scientifically rigorous HEOR programmes from conception through execution, publication, and stakeholder engagement, including cost-effectiveness models, budget-impact analyses, indirect treatment comparisons, systematic reviews, burden-of-illness studies, cost-of-illness research, humanistic outcomes, productivity assessments, and patient preference studies.
Publication and Scientific Communication: Oversee the global HEOR publication and dissemination strategy in collaboration with Scientific Communications. Ensure research findings are effectively communicated through scientific congresses, peer-reviewed publications, and proactive and reactive evidence communication materials.
Global Market Access and HTA Support: Ensure HEOR evidence and economic models are appropriate for global and regional payer submissions and HTA assessments. Provide expert guidance to local affiliates on evidence adaptation, model validation, and responses to HTA questions.
External Partner Management: Select, manage, and oversee external research collaborators, academic institutions, and vendors. Maintain accountability for scientific quality, contractual obligations, regulatory compliance, and value for money across outsourced research programmes.
External Stakeholder Engagement: Build relationships with payers, HTA organisations, key opinion leaders, professional societies, and patient advocacy groups in partnership with Market Access and Medical Affairs teams.
Scientific Presentations and Advisory Support: Prepare and deliver HEOR presentations to formulary committees, HTA bodies, and other healthcare decision-makers when required. Respond confidently to scientific, economic, and methodological questions.
Thought Leadership: Develop and maintain relationships with leading HEOR academics and scientific experts, contributing to methodological advances and research priorities relevant to rare autoimmune diseases.
Strategic Communication: Translate complex scientific and economic evidence into clear, persuasive narratives for diverse audiences, including senior executives, clinicians, payers, healthcare stakeholders, and patients.
Functional Development: Contribute to broader Global HEOR strategy, operating models, scientific standards, vendor selection, and technology platform decisions beyond the immediate marketed product portfolio.